AGP Executive Report
Last update: a few seconds agoFederal Policy Shift: The DOJ’s move to downgrade medical marijuana from Schedule I to Schedule III is expected to unlock some federal tax benefits and spur new research, but states still face a patchwork with the DEA set to hold a first hearing on broader de-scheduling. Local Market Pressure: D.C. is weighing a big medical cannabis tax hike (over 70% for FY27) that operators warn could be the “last straw” in an oversaturated market. Regulatory Watch: Japan has banned the hemp cannabinoid CBN after reports tied to illnesses and risky behavior, allowing it only for rare epilepsy cases under strict conditions. Business & Retail: Sweetspot Cannabis Dispensary opened in Hamilton, NJ, expanding its East Coast footprint, while Curaleaf workers in Phoenix decertified a union after contract talks. Community Rules: Illinois lawmakers advanced hemp oversight and consumer protections, and Fillmore County, Minnesota, debated a cannabis setback buffer that could block a microbusiness near a church. Industry Growth: A CBD nutraceuticals market report projects rapid global expansion as wellness demand accelerates.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
